With 63935.0 shares changed hands, the volume of the stock remained heavier than its average volume of 34960.0 shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $23.4533 whereas the lowest price it dropped to was $19.99. The 52-week range on BNR shows that it touched its highest point at $19.50 and its lowest point at $2.18 during that stretch. It currently has a 1-year price target of $73.05. Beta for the stock currently stands at 1.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BNR was up-trending over the past week, with a rise of 33.13%, but this was up by 74.06% over a month. Three-month performance surged to 157.42% while six-month performance rose 573.19%. The stock gained 216.15% in the past year, while it has gained 364.92% so far this year.
Float and Shares Shorts:
At present, 9.03 million BNR shares are outstanding with a float of 9.01 million shares on hand for trading. On 2025-11-14, short shares totaled 33338.0, which was 31.0 higher than short shares on 1760486400. In addition to Mr. Yusheng Han as the firm’s Founder, Chairman & CEO, Ms. Xiaozhi Hu serves as its Senior Director of Finance.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, BNR reported revenue of $131617000.0 and operating income of -$16131000.0. The EBITDA in the recently reported quarter was -$14380000.0 and diluted EPS was -$1.6.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$19.50085 being high and -$19.50085 being low. For BNR, this leads to a yearly average estimate of -$19.50085. The surprise factor in the prior quarter was -$19.
